Antimicrobial Resistance and Zoonoses

Dear Colleagues,

Antimicrobial resistance in bacteria with zoonotic potential is of special significance to a correlation between human health, animal health, and the environment underlying the One Health concept. The phenomenon of antimicrobial resistance remains poorly recognized in some important zoonotic pathogens. There is still limited data on resistance phenotypes and mechanisms in zoonotic species belonging to the genera such as Rickettsia, Chlamydia, Coxiella, Borrelia, Leptospira, Brucella, Francisella, or Mycoplasma. It should be highlighted that those bacteria are frequently multi-host pathogens infecting domestic as well as wild animals; moreover, some of them are able to grow in the environment, while others are transmitted by different vectors. Various factors, including those causing a co-selection effect, may influence such bacteria, leading to development of acquired antimicrobial resistance. In this context, every piece of research on the resistance determinants and every surveillance of their dissemination or every monitoring the spread of resistant strains in different geographical regions, providing new data on the antimicrobial resistance in zoonotic pathogens, is particularly valuable for both human and veterinary medicine.

Therefore, we introduce this Special Issue of Antibiotics to encourage you to submit research in all aspects of antimicrobial resistance in bacteria causing zoonoses, the above-mentioned pathogens as well as better described zoonotic agents such as Campylobacter spp., Vibrio spp., Salmonella spp., staphylococci, Actinomycetales, and many others. We welcome original research or review papers that may improve our knowledge in this area.

Dr. Magdalena Rzewuska
Prof. Dr. Marina Spînu
Dr. Lucjan Witkowski
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.